CNR Institutional Research Information System

AROSIO, DANIELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.576
NA - Nord America 857
EU - Europa 307
SA - Sud America 262
AF - Africa 18
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.024
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 817
SG - Singapore 617
CN - Cina 484
BR - Brasile 216
VN - Vietnam 146
HK - Hong Kong 114
KR - Corea 95
IT - Italia 82
FR - Francia 81
JP - Giappone 28
DE - Germania 26
AR - Argentina 22
CA - Canada 21
IN - India 21
GB - Regno Unito 20
FI - Finlandia 18
NL - Olanda 17
IL - Israele 12
IQ - Iraq 12
PL - Polonia 10
BD - Bangladesh 9
ES - Italia 9
MX - Messico 9
ID - Indonesia 8
TR - Turchia 8
SE - Svezia 6
UA - Ucraina 6
CO - Colombia 5
EC - Ecuador 5
HU - Ungheria 5
ZA - Sudafrica 5
CL - Cile 4
EG - Egitto 4
IE - Irlanda 4
UZ - Uzbekistan 4
BE - Belgio 3
CZ - Repubblica Ceca 3
HN - Honduras 3
MA - Marocco 3
RU - Federazione Russa 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
CH - Svizzera 2
JM - Giamaica 2
KG - Kirghizistan 2
LB - Libano 2
LT - Lituania 2
NZ - Nuova Zelanda 2
PE - Perù 2
PH - Filippine 2
PR - Porto Rico 2
PT - Portogallo 2
RS - Serbia 2
SA - Arabia Saudita 2
TH - Thailandia 2
TN - Tunisia 2
VE - Venezuela 2
AT - Austria 1
AU - Australia 1
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GH - Ghana 1
GY - Guiana 1
HT - Haiti 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MY - Malesia 1
NO - Norvegia 1
PK - Pakistan 1
PS - Palestinian Territory 1
PY - Paraguay 1
RW - Ruanda 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TT - Trinidad e Tobago 1
Totale 3.024
Salva come PNG Salva come JPEG
Città #
Santa Clara 382
Singapore 332
Hefei 224
Hong Kong 114
Seoul 93
San Jose 86
Beijing 75
Lauterbourg 67
Ashburn 56
Ho Chi Minh City 51
Los Angeles 40
Hanoi 38
Milan 29
São Paulo 16
Minamishinagawa 14
Tokyo 13
Helsinki 11
Rome 10
Atlanta 9
Düsseldorf 9
Rio de Janeiro 9
Warsaw 9
Bengaluru 8
Buffalo 8
Dallas 8
Brasília 7
Frankfurt am Main 7
Lappeenranta 7
New York 7
Phoenix 7
Ottawa 6
Stockholm 6
Budapest 5
Haiphong 5
Montreal 5
Mumbai 5
Amsterdam 4
Baghdad 4
Can Tho 4
Curitiba 4
Da Nang 4
Johannesburg 4
Juiz de Fora 4
London 4
Mexico City 4
Málaga 4
Tashkent 4
Belo Horizonte 3
Bielefeld 3
Biên Hòa 3
Bodio Lomnago 3
Brussels 3
Goiânia 3
Houston 3
Montevideo 3
Orem 3
Prague 3
Quito 3
Santa Maria 3
Sorocaba 3
Thu Dau Mot 3
Alexandria 2
Americana 2
Bexley 2
Bishkek 2
Boardman 2
Bragança Paulista 2
Buenos Aires 2
Calgary 2
Campo Largo 2
Caxias do Sul 2
Chicago 2
Council Bluffs 2
Cuiabá 2
Denver 2
Des Moines 2
Dublin 2
Elk Grove Village 2
Fayetteville 2
Florence 2
Fortaleza 2
Gallarate 2
Go Vap 2
Guarulhos 2
Guro-gu 2
Gustavo Adolfo Madero 2
Ha Long 2
Iguatu 2
Itaquaquecetuba 2
Kula 2
La Plata 2
Lençóis Paulista 2
Lima 2
Limeira 2
Manchester 2
Marília 2
Mesquita 2
Miami 2
Milwaukee 2
Naples 2
Totale 1.942
Salva come PNG Salva come JPEG
Nome #
Multimeric Presentation of RGD Peptidomimetics Enhances Integrin Binding and Tumor Cell Uptake 88
Synthesis and biological evaluation of dual action cyclo-RGD/SMAC mimetic conjugates targeting alphavbeta3/alphavbeta5 integrins and IAP proteins 88
Shifting Towards alpha(V)beta(6)Integrin Ligands Using Novel Aminoproline-Based Cyclic Peptidomimetics 82
Investigating the Interaction of Cyclic RGD Peptidomimetics with alphaVbeta6 Integrin by Biochemical and Molecular Docking Studies. 73
4-Connected azabicyclo[5.3.0]decane Smac mimetics-Zn2+ chelators as dual action antitumoral agents 71
Peptidomimetic compounds and preparation of biologically active derivatives 69
MicroPET/CT imaging of alphavbeta3 integrin via a novel 68Ga-NOTA-RGD peptidomimetic conjugate in rat myocardial infarction 68
Interfering with the Tumor-Immune Interface: Making Way for Triazine-Based Small Molecules as Novel PD-L1 Inhibitors 67
Synthesis of Novel c(AmpRGD)-Sunitinib Dual Conjugates as Molecular Tools Targeting the ?v?3 Integrin/VEGFR2 Couple and Impairing Tumor-Associated Angiogenesis 62
Kiss and Run: Promoting Effective and Targeted Cellular Uptake of a Drug Delivery Vehicle Composed of an Integrin-Targeting Diketopiperazine Peptidomimetic and a Cell-Penetrating Peptide 62
Integrin targeted synthetic ligands for diagnostic and therapeutic applications 57
Iron oxide-gold core-shell nanoparticles as multimodal imaging contrast agent 57
Squalene-Based Nano-Assemblies Improve the Pro-Autophagic Activity of Trehalose 56
Intracisternal delivery of PEG-coated gold nanoparticles results in high brain penetrance and long-lasting stability 55
Design, synthesis and biological evaluation of novel dimeric and tetrameric cRGD-paclitaxel conjugates for integrin-assisted drug delivery 55
Cyclic RGD Peptidomimetics Containing Bifunctional Diketopiperazine Scaffolds as New Potent Integrin Ligands 54
Identification of new selective CD36 inhibitors to potentiate HER2-targeted therapy in HER2-positive breast cancer 54
A new optical imaging probe targeting alphaVbeta3 integrin in glioblastoma xenografts 53
Trehalose-based neuroprotective autophagy inducers 53
HuR-targeted agents: An insight into medicinal chemistry, biophysical, computational studies and pharmacological effects on cancer models 47
Synthesis of Gd and (68) Ga Complexes in Conjugation with a Conformationally Optimized RGD Sequence as Potential MRI and PET Tumor-Imaging Probes 47
Novel, soluble 3-heteroaryl-substituted tanshinone mimics attenuate the inflammatory response in murine macrophages 46
Synthesis and preclinical evaluation of a novel, selective 111In-labelled aminoproline-RGD-peptide for non-invasive melanoma tumor imaging 45
Tumor Targeting with an isoDGR-Drug Conjugate 43
Theoretical and experimental studies on the interaction of biphenyl ligands with human and murine PD-L1: Up-to-date clues for drug design 43
Effective Targeting of DC-SIGN by alpha-Fucosylamide Functionalized Gold Nanoparticles 43
HuR modulation counteracts lipopolysaccharide response in murine macrophages 42
RGD Cyclopeptide Equipped with a Lysine-Engaging Salicylaldehyde Showing Enhanced Integrin Affinity and Cell Detachment Potency 41
Preparation of cyclic RGD peptidomimetic-paclitaxel conjugates targeting integrin ?V?3 for use as anticancer agents 41
Dual action Smac mimetics-zinc chelators as pro-apoptotic antitumoral agents 41
Cyclic RGD Functionalized Gold Nanoparticles for Tumor Targeting 40
Computational design of novel peptidomimetic inhibitors of cadherin homophilic interactions 39
Enhancement of the Uptake and Cytotoxic Activity of Doxorubicin in Cancer Cells by Novel cRGD-Semipeptide-Anchoring Liposomes 39
Bisphosphonate-functionalized cyclic Arg-Gly-Asp peptidomimetics 39
Cyclic isoDGR and RGD Peptidomimetics Containing Bifunctional Diketopiperazine Scaffolds are Integrin Antagonists 38
A dimeric bicyclic RGD ligand displays enhanced integrin binding affinity and strong biological effects on U-373 MG glioblastoma cells 38
Cyclic RGD and iso DGR Integrin Ligands Containing cis-2-amino-1-cyclopentanecarboxylic ( cis-Beta-ACPC) Scaffolds 38
Conjugates of Cryptophycin and RGD or isoDGR Peptidomimetics for Targeted Drug Delivery 38
Integrin-Mediated Drug Delivery in Cancer and Cardiovascular Diseases with Peptide-Functionalized Nanoparticles 37
A combined approach of structure-based virtual screening and NMR to interrupt the PD-1/PD-L1 axis: Biphenyl-benzimidazole containing compounds as novel PD-L1 inhibitors 37
beta-Glucuronidase triggers extracellular MMAE release from an integrin-targeted conjugate 37
Integrin-targeted peptide- and peptidomimetic-drug conjugates for the treatment of tumors. 36
Design, Synthesis, and Biological Evaluation of Novel cRGD- Paclitaxel Conjugates for Integrin-Assisted Drug Delivery 35
Synthesis and Biological Evaluation of RGD Peptidomimetic-Paclitaxel Conjugates Bearing Lysosomally Cleavable Linkers 34
Molecular targeting of imaging and drug delivery probes in Atherosclerosis 34
Rational Design of Antiangiogenic Helical Oligopeptides Targeting the Vascular Endothelial Growth Factor Receptors 34
Functionalised azabicycloalkane amino acids by nitrone 1,3-dipolar intramolecular cycloaddition 33
New potent alpha(v)beta(3) integrin ligands based on azabicycloalkane (gamma,alpha)-dipeptide mimics 33
Stereodivergent synthesis of 5-aminopipecotic acids and application in the preparation of a cyclic RGD peptidomimetic as a nanomolar alpha(v)beta(3) integrin ligand 32
Neutrophil Elastase Promotes Linker Cleavage and Paclitaxel Release from an Integrin-Targeted Conjugate 32
Synthesis, Characterization, and Biological Evaluation of a Dual-Action Ligand Targeting alpha(v)beta(3) Integrin and VEGF Receptors 31
Click chemistry to functionalise peptidomimetics 31
Synthesis and Preliminary Evaluation of Tanshinone Mimic Conjugates for Mechanism of Action Studies 31
Synthesis and biological evaluation of RGD and isoDGR peptidomimetic-alpha-amanitin conjugates for tumor-targeting 29
A synthetic divalent cholera toxin glycocalix[4]arene ligand having higher affinity than natural GM1 oligosaccharide 28
Stereoselective synthesis of conformationally constrained cyclohexanediols: A set of molecular scaffolds for the synthesis of glycomimetics 28
Synthesis and cholera toxin binding properties of multivalent GM1 mimics 28
Cyclic RGD-Containing Functionalized Azabicycloalkane Peptides as Potent Integrin Antagonists for Tumor Targeting 27
Ganglioside GM1 mimics: Lipophilic substituents improve affinity for cholera toxin 27
Synthesis and Biological Evaluation of RGD and isoDGR-Monomethyl Auristatin Conjugates Targeting Integrin (V3) 26
Functionalized Cyclic RGD Peptidomimetics: Conjugable ligands for alpha(v)beta(3) Receptor Imaging 26
Mimics of Ganglioside GM1 as Cholera Toxin Ligands: Replacement of the GalNAC Residue 26
Characterization of iron oxide-gold core-shell multifunctional nanoparticles in biomedical imaging 26
Advancement in integrin facilitated drug delivery 26
Synthesis and Biological Evaluation (in Vitro and in Vivo) of Cyclic Arginine-Glycine-Aspartate (RGD) Peptidomimetic-Paclitaxel Conjugates Targeting Integrin alphaVbeta3 25
Solid phase immunoadsorption for therapeutic and analytical studies on neuropathy-associated anti-GM1 antibodies 25
Synthesis of non glycosidic nucleobase-sugar mimetics 25
Insights into the Binding of Cyclic RGD Peptidomimetics to ?5?1 Integrin by using Live-Cell NMR And Computational Studies 25
Multivalency Increases the Binding Strength of RGD Peptidomimetic-Paclitaxel Conjugates to Integrin ?V?3 24
Cyclic isoDGR Peptidomimetics as Low-Nanomolar alphavbeta3 Integrin Ligands 23
Intramolecular carbohydrate-aromatic interactions and intermolecular van der Waals interactions enhance the molecular recognition ability of GMI glycomimetics for cholera toxin 23
Mimicking gangliosides by design: Mimics of GM1 headgroup 23
A Potent Integrin Antagonist from a Small Library of Cyclic RGD Pentapeptide Mimics Including Benzyl-Substituted Azabicycloalkane Amino Acids 22
Synthesis and Biological Evaluation of Paclitaxel Conjugates Involving Linkers Cleavable by Lysosomal Enzymes and alvhaVbeta3-Integrin Ligands for Tumor Targeting 21
Targeting Integrin ?V?3 with Theranostic RGD-Camptothecin Conjugates Bearing a Disulfide Linker: Biological Evaluation Reveals a Complex Scenario 21
Improved synthesis of both enantiomers of trans-cyclohex-4-ene-1,2-dicarboxylic acid 21
Solid-phase synthesis of combinatorial libraries based on enatiomerically pure (1S,2S,4R,5S)-4,5-dihydroxycyclohexan-1,2-dicarboxylic acid scaffolds 20
Totale 3.114
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.346
article - articoli 10.812
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.158
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202413 0 0 0 0 0 0 0 0 2 0 10 1
2024/20251.305 0 3 88 52 305 120 61 102 11 39 285 239
2025/20261.787 106 229 164 331 342 53 246 70 96 52 46 52
2026/20279 9 0 0 0 0 0 0 0 0 0 0 0
Totale 3.114